Skip to main content
Clinical Trials/NCT01032967
NCT01032967
Completed
Phase 3

Multicenter Prospective Randomized Trial Comparing Standard Esophagectomy With Chemoradiotherapy for Treatment of Squamous Esophageal Cancer: Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)

Chinese University of Hong Kong0 sites40 target enrollmentJuly 2000

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Esophageal Cancers
Sponsor
Chinese University of Hong Kong
Enrollment
40
Primary Endpoint
Overall survival and disease-free survival
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The aim of this study is to compare outcomes in patients with operable squamous carcinoma of the esophagus who have received either surgery or definitive chemoradiation (CRT).

Registry
clinicaltrials.gov
Start Date
July 2000
End Date
June 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Eligible patients had mid or lower thoracic esophageal cancers that were confirmed on histology to be a squamous cell carcinoma deemed to be resectable.

Exclusion Criteria

  • The investigators excluded those patients who had distant metastasis to solid visceral organs or local invasion into trachea, descending aorta, or recurrent laryngeal nerve.
  • Those patients who were older than 75 years or who had a serious premorbid condition or a poor physical status that compromised a thoracotomy were also excluded.

Outcomes

Primary Outcomes

Overall survival and disease-free survival

Time Frame: 2 year and 5 year

Secondary Outcomes

  • Quality of life and function outcomes(2 year)

Similar Trials